Figure 1.
No differences of complete cytogenetic response rate (A) or major molecular response rate between patients with versus without deletion of derivative chromosome 9 after imatinib mesylate therapy
No differences of complete cytogenetic response rate (A) or major molecular response rate between patients with versus without deletion of derivative chromosome 9 after imatinib mesylate therapy
